Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Response Biomedical Corp T.RBM

Sector: Healthcare | Sub-Sector: Medical Devices
Alternate Symbol(s):  RPBIF

Response Biomedical Corp is engaged in the research, development, commercialization and distribution of diagnostic technologies for the medical central-lab testing, point of care (POC) testing and on-site environmental testing markets.
Price: $1.25 | Change: +$0.02 | %Change: +1.63%
Volume: 8,533 | Day High/Low: 1.25/1.25 | 52 Week High/Low: 3.00/1.20


Last Traded: September 19, 2014 05:59 Transaction Volume: 8,533
Open: $1.25 Previous Close: $1.23
Bid: $1.28 Ask: $1.35
Bid Size: 3,000 Ask Size: 200
Market Cap: $9.9m Shares Out: 7.9m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest Bullboard Posts

  • In any case RBM is moving ahead

    0 stars

    I think RBM has become a more clearly focus company than it has ever been since Orbimed has taken control.  They made the decision to...

    3 stars

  • Radvak was...

    0 stars

    Well, Bill Radvak was my favorite CEO. Back in those days, there was so much promise and the stock was liquid and money could be made...

    4 stars

  • Purvin resigns as CEO

    0 stars

    Not sure what to make of this... On the one hand, Purvin seemed to have the right credentials and you would have expected that he could...

    3 stars

  • Geez Yoska

    0 stars

    Your logic doesnt really seem to apply to every other company in the world? Have you looked at any stock index lately? I hate rbm You...

    2.5 stars

  • RE:The stench continues

    0 stars

    Just the BOD's are only one's on the payroll playing musical chairs I believe. Sales are very bleak and can't understand why, with half...

    4 stars